http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-036076-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C225-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-06
filingDate 2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2004-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-036076-A1
titleOfInvention ARILAMINOPROPAN ANALOG COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND THE USE OF SUCH ANALOGS FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF GLAUCOMA
abstract An arylaminopropane analog compound represented by the formula (1), in which: R1, R2 and R3 are independently selected from hydrogen or an alkyl group; R4 is H or OR1; R5 is OCON (R1, R2), OCOR1 or OR7; R6 is H, OR7, CONR1R2, CH2OR7, CO2R1R2 or N (R1R2), with the proviso that R5 and R6 are not H in both cases; aryl represents at least one aryl group; A is chosen from hydrogen, an alkyl group, C (= O) OR7, OR7, CR7, C (= O) NR1R2, SO2 (R1R2), halogen or CF3; and R7 is H, a substituted or unsubstituted alkyl group, CONR1R2C1-3, N (R1R2) C1-3, CO2HC1-3 or CO2C1-3-C1-3 alkyl; pharmaceutical compositions and the use of said analogs for the preparation of a medicament for reducing and controlling normal or elevated intraocular pressure, as well as for the treatment of glaucoma using compositions containing one or more of said compounds.
priorityDate 2001-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 24.